The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance

Mol Cell Biochem. 2021 Apr;476(4):1729-1739. doi: 10.1007/s11010-020-04015-y. Epub 2021 Jan 11.

Abstract

The high mobility group protein B (HMGB) family (including HMGB1, HMGB2, HMGB3, and HMGB4) can regulate the mechanisms of DNA replication, transcription, recombination, and repair, and act as cytokines to mediate responses to infection, injury, and inflammation. HMGB1/2/3 has a high similarity in sequence and structure, while HMGB4 has no acidic C-terminal tail. Among them, HMGB3 can regulate the self-renewal and differentiation of normal hematopoietic stem cell population, but the decrease of its expression is easy to induce leukemia. Up-regulation of its expression promotes tumor development and chemotherapy resistance through a variety of mechanisms, and non-coding RNA can regulate to promote tumor cell proliferation, invasion, and migration and inhibit cancer cell apoptosis.

Keywords: DNA; High mobility group-box 3; Hypoxia-inducible factor-1α; Tumor; microRNA.

Publication types

  • Review

MeSH terms

  • Cell Proliferation*
  • Drug Resistance, Neoplasm*
  • HMGB3 Protein / metabolism*
  • Humans
  • Neoplasm Proteins / metabolism*
  • Neoplasms / metabolism*
  • Neoplasms / pathology

Substances

  • HMGB3 Protein
  • Neoplasm Proteins